Two new associated partners join the EuPRAXIA consortium

2017 - 12 - 11

The Ferdinand-Braun-Institut, Leibinz-Institut für Höchstfrequenztechnik (FBH) is one of the world’s leading institutes for applied research in microwaves and optoelectronics, based on III-V semiconductors. Among other activities, FBH develops and manufactures efficient high-power diode lasers with excellent beam quality for integration into pumping modules. EuPRAXIA depends on the access to the highest performance pump lasers and the FBH has the skills, experience, technology and contacts to ensure their availability.

Queens University Belfast has done pioneering research in laser-driven particle acceleration through its Centre of Plasma Physics (CPP). CPP is particularly active in the use of laser-driven secondary sources and may provide an invaluable contribution to the development of high-gradient acceleration structures and high-quality positron beam sources. Moreover, CPP is committed to provide collaborative access to their own high-power laser system TARANIS.

The Collaboration Board of EuPRAXIA, which comprises representatives from the 16 beneficiary partners of the consortium, has approved the incorporation of two new associated partners during a session held on 21st November at the EuPRAXIA Yearly Meeting in Lisbon.

The two new partners are Queen's University Belfast (UK) and the Ferdinand-Braun-Institute of Berlin (Germany), represented by Dr Gianluca Sarri and Dr Paul Crump respectively.

With these new incorporations, the EuPRAXIA family rises to a total of 40 member institutions. We wish the new partners a successful participation in the project. ​